169 related articles for article (PubMed ID: 29920533)
21. In Vitro Evaluation of the Reductase Activities of Human
Takano S; Fukami T; Ichida H; Suzuki K; Nakano M; Nakajima M
Drug Metab Dispos; 2023 Sep; 51(9):1188-1195. PubMed ID: 37344179
[TBL] [Abstract][Full Text] [Related]
22. Is prostate cancer stage migration continuing for black men in the PSA era?
Dobbs RW; Greenwald DT; Wadhwa H; Freeman VL; Abern MR
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):210-215. PubMed ID: 28094251
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation.
Sun SQ; Gu X; Gao XS; Li Y; Yu H; Xiong W; Yu H; Wang W; Li Y; Teng Y; Zhou D
Oncotarget; 2016 Jul; 7(30):48050-48058. PubMed ID: 27385003
[TBL] [Abstract][Full Text] [Related]
24. Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor.
Morsy A; Trippier PC
ACS Chem Biol; 2020 Mar; 15(3):646-650. PubMed ID: 32125151
[TBL] [Abstract][Full Text] [Related]
25. Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
Chavan SV; Maitra A; Roy N; Chavan PR
Indian J Med Res; 2014 Mar; 139(3):371-8. PubMed ID: 24820830
[TBL] [Abstract][Full Text] [Related]
26. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
Weinrich SP
Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
[TBL] [Abstract][Full Text] [Related]
28. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
[TBL] [Abstract][Full Text] [Related]
29. Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.
Sucheston LE; Bensen JT; Xu Z; Singh PK; Preus L; Mohler JL; Su LJ; Fontham ET; Ruiz B; Smith GJ; Taylor JA
PLoS One; 2012; 7(3):e30950. PubMed ID: 22479307
[TBL] [Abstract][Full Text] [Related]
30. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
Zagars GK; Pollack A; Pettaway CA
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
[TBL] [Abstract][Full Text] [Related]
32. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
Beebe-Dimmer JL; Lange LA; Cain JE; Lewis RC; Ray AM; Sarma AV; Lange EM; Cooney KA
Prostate Cancer Prostatic Dis; 2006; 9(1):50-5. PubMed ID: 16247489
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles combined with AKR1C3 siRNA inhibited the growth of castration-resistant prostate cancer by suppressing androgen synthesis in vitro and in vivo.
Chen J; Yang Y; Xu D; Li J; Wu S; Jiang Y; Wang C; Yang Z; Zhao L
Biochem Biophys Res Commun; 2021 Feb; 540():83-89. PubMed ID: 33450484
[TBL] [Abstract][Full Text] [Related]
35. Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.
Dickey SL; Cormier EM; Whyte J; Graven L; Ralston PA
Public Health Nurs; 2016 Nov; 33(6):483-492. PubMed ID: 26790837
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
37. Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.
Cramer SD; Sun J; Zheng SL; Xu J; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2451-7. PubMed ID: 18768516
[TBL] [Abstract][Full Text] [Related]
38. Racial Variation in the Outcome of Subsequent Prostate Biopsies in Men With an Initial Diagnosis of Atypical Small Acinar Proliferation.
Scott Libby R; Kramer JJ; Tue Nguyen HM; Feibus A; Thomas R; Silberstein JL
Clin Genitourin Cancer; 2017 Dec; 15(6):e995-e999. PubMed ID: 28566201
[TBL] [Abstract][Full Text] [Related]
39. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
[TBL] [Abstract][Full Text] [Related]
40. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
